{
    "2019-11-13": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Ex-Novartis exec named as Flagship's ‘matchmaker’ for Big Pharma partnerships",
                "features": {
                    "keywords": [
                        "Ex-Novartis",
                        "exec",
                        "Flagship",
                        "Big Pharma",
                        "partnerships"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Top Analyst Reports for Microsoft, Novartis & Novo Nordisk",
                "features": {
                    "keywords": [
                        "Top Analyst",
                        "Reports",
                        "Microsoft",
                        "Novartis",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}